Opportunity Information: Apply for RFA DA 26 002

The Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed) funding opportunity (RFA-DA-26-002) is a National Institutes of Health (NIH) grant that supports early-stage, exploratory research aimed at clarifying how HIV infection and/or antiretroviral therapy (ART) intersect with substance use disorder (SUD)-relevant biology at single-cell resolution. The central idea is to take advantage of existing or newly generated single-cell datasets (for example, single-cell transcriptomic and epigenomic data) to pinpoint specific cell types and molecular features that appear to drive or reflect HIV/ART-related and opioid/SUD-related responses, and then to follow up with lab-based functional validation to test whether those computational signals represent real biological mechanisms.

The NOFO focuses on two tightly connected types of work. First, it supports data mining of single-cell datasets to identify candidate cell populations, transcripts, enhancers, or broader transcriptional networks that are implicated in molecular responses relevant to HIV/ART and SUD. This includes efforts to discover which specific cells respond to opioids or other SUD-relevant exposures in the context of HIV or ART, and what gene regulatory elements or gene expression programs are involved. Second, it supports functional validation studies designed to confirm or refute the biological role of those candidates. Examples explicitly mentioned include epigenomic or transcriptomic manipulation and high-throughput secondary screening, which could involve perturbing candidate regulatory elements or genes and measuring downstream effects to establish causality rather than simple correlation.

The award mechanism is an NIH R21, meaning it is intended for exploratory, proof-of-concept projects that can open up a new direction or rapidly test a promising idea rather than support a large, long-term research program. Clinical trials are not allowed under this announcement, so projects must be non-clinical-trial in nature (for instance, computational analyses, mechanistic studies in model systems, cell-based assays, organoids, or other experimental validation approaches that do not meet NIH’s definition of a clinical trial).

Key administrative details include an application closing date of March 19, 2026, and an award ceiling listed at $275,000. The opportunity is categorized as discretionary funding and uses the grant funding instrument. It falls under CFDA number 93.279 (NIH research and development programs).

Eligibility is broad and includes many types of U.S. organizations and governments, such as state, county, and local governments; federally recognized Native American tribal governments; public and private institutions of higher education; independent school districts; special district governments; public housing authorities/Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations other than small businesses; and small businesses. The NOFO also explicitly highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, tribal governments that are not federally recognized, regional organizations, and non-U.S. entities (foreign organizations). This wide eligibility signals an interest in drawing expertise from diverse institutional settings and encouraging participation from organizations that serve underrepresented communities or have specialized regional or population knowledge.

In practical terms, a competitive project under this NOFO would typically (1) leverage single-cell data to generate specific, testable hypotheses about HIV/ART and opioid or SUD-related molecular pathways in particular cell types, then (2) use appropriately designed experimental validation to determine whether the implicated genes, enhancers, or regulatory networks actually control relevant responses. The overall goal is to move from large, complex single-cell datasets to validated mechanistic insights that can better explain how HIV/ART biology and opioid/SUD biology interact at the level of individual cells and gene regulation.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2024-08-14.
  • Applicants must submit their applications by 2026-03-19. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $275,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 26 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Mining Companies

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: BJA FY24 Invited to Apply- Administrative Funding Adjustment to BJA Previously Funded Awards 9

Previous opportunity: Postdoctoral Research Fellowships in Biology

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 26 002

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 26 002) also looked into and applied for these:

Funding Opportunity
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed) Apply for RFA DA 26 001

Funding Number: RFA DA 26 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R21 Clinical Trials Not Allowed) Apply for RFA DA 26 008

Funding Number: RFA DA 26 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R01 Clinical Trials Not Allowed) Apply for RFA DA 26 007

Funding Number: RFA DA 26 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional) Apply for RFA CA 25 011

Funding Number: RFA CA 25 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional) Apply for RFA CA 25 012

Funding Number: RFA CA 25 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 24 274

Funding Number: PAR 24 274
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed) Apply for RFA DA 25 063

Funding Number: RFA DA 25 063
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional) Apply for PAR 24 273

Funding Number: PAR 24 273
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NLM Information Resource Grants to Reduce Health Disparities and Promote Health Equity (G08 Clinical Trial Not Allowed) Apply for PAR 24 281

Funding Number: PAR 24 281
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) Apply for PAR 25 043

Funding Number: PAR 25 043
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) Apply for PAR 25 044

Funding Number: PAR 25 044
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) Apply for PAR 24 277

Funding Number: PAR 24 277
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Apply for PAR 24 291

Funding Number: PAR 24 291
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 073

Funding Number: RFA DA 25 073
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) Apply for PAR 24 297

Funding Number: PAR 24 297
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional) Apply for PAR 24 298

Funding Number: PAR 24 298
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) Apply for PAR 24 299

Funding Number: PAR 24 299
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional) Apply for RFA NR 25 001

Funding Number: RFA NR 25 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) Apply for PAR 25 051

Funding Number: PAR 25 051
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed) Apply for RFA CA 24 036

Funding Number: RFA CA 24 036
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,999

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 26 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: